Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)

Authors

Chuan Liu

Published

July 11, 2024

Share your thoughts on this paper...

Supporters

Support the authors with ResearchCoin

Journal

Clinical and Molecular Hepatology

Topics

DOI

10.3350/cmh.2024.0198

License

CC-BY-NC

Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)

Authors

Chuan Liu

Published

July 11, 2024

Share your thoughts on this paper...

Supporters

Support the authors with ResearchCoin

Journal

Clinical and Molecular Hepatology

Topics

DOI

10.3350/cmh.2024.0198

License

CC-BY-NC

Paper

Paper

Paper

Paper

Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)

Supporters

Journal

Topics

DOI

License

Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)

Supporters

Journal

Topics

DOI

License

Supporters

Journal

Topics

DOI

License